These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3391862)

  • 1. Pharmacokinetic study of the interaction between rifampicin and ketoconazole.
    Doble N; Shaw R; Rowland-Hill C; Lush M; Warnock DW; Keal EE
    J Antimicrob Chemother; 1988 May; 21(5):633-5. PubMed ID: 3391862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
    Pilheu JA; Galati MR; Yunis AS; De Salvo MC; Negroni R; García Fernández JC; Mingolla L; Rubio MC; Masana M; Acevedo C
    Medicina (B Aires); 1989; 49(1):43-7. PubMed ID: 2698437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact on abiraterone pharmacokinetics and safety: Open-label drug-drug interaction studies with ketoconazole and rifampicin.
    Bernard A; Vaccaro N; Acharya M; Jiao J; Monbaliu J; De Vries R; Stieltjes H; Yu M; Tran N; Chien C
    Clin Pharmacol Drug Dev; 2015 Jan; 4(1):63-73. PubMed ID: 27128004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK.
    Nguyen L; Holland J; Miles D; Engel C; Benrimoh N; O'Reilly T; Lacy S
    J Clin Pharmacol; 2015 Sep; 55(9):1012-23. PubMed ID: 25854986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ketoconazole and Rifampicin on the Pharmacokinetics of Nintedanib in Healthy Subjects.
    Luedtke D; Marzin K; Jungnik A; von Wangenheim U; Dallinger C
    Eur J Drug Metab Pharmacokinet; 2018 Oct; 43(5):533-541. PubMed ID: 29500603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults.
    Kusawake T; den Adel M; Groenendaal-van de Meent D; Garcia-Hernandez A; Takada A; Kato K; Ohtsu Y; Katashima M
    Adv Ther; 2017 Nov; 34(11):2466-2480. PubMed ID: 29076107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.
    López-Cortés LF; Ruiz-Valderas R; Viciana P; Alarcón-González A; Gómez-Mateos J; León-Jimenez E; Sarasanacenta M; López-Pua Y; Pachón J
    Clin Pharmacokinet; 2002; 41(9):681-90. PubMed ID: 12126459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide.
    Hatorp V; Hansen KT; Thomsen MS
    J Clin Pharmacol; 2003 Jun; 43(6):649-60. PubMed ID: 12817528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic Interaction of Rifampicin with Oral Versus Intravenous Anticancer Drugs: Challenges, Dilemmas and Paradoxical Effects Due to Multiple Mechanisms.
    Srinivas NR
    Drugs R D; 2016 Jun; 16(2):141-8. PubMed ID: 27098526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased systemic exposure of fimasartan, an angiotensin II receptor antagonist, by ketoconazole and rifampicin.
    Kim JW; Yi S; Kim TE; Lim KS; Yoon SH; Cho JY; Lee MG; Song IS; Shin SG; Jang IJ; Yu KS
    J Clin Pharmacol; 2013 Jan; 53(1):75-81. PubMed ID: 23400746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Mycobacterium tuberculosis in acquired immune deficiency syndrome.
    Doble N; Hykin P; Shaw R; Keal EE
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):849-50. PubMed ID: 3931740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction between efavirenz and ketoconazole in rats.
    Saadeddin A; Peris JE
    Xenobiotica; 2009 Feb; 39(2):135-9. PubMed ID: 19255939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of Rifampin and Ketoconazole on the blood and liver concentration of atorvastatin in wild-type and Cyp3a and Oatp1a/b knockout mice.
    Chang JH; Ly J; Plise E; Zhang X; Messick K; Wright M; Cheong J
    Drug Metab Dispos; 2014 Jun; 42(6):1067-73. PubMed ID: 24671957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-drug interactions between moxifloxacin and rifampicin based on pharmacokinetics in vivo in rats.
    Huang L; Liu J; Yu X; Shi L; Liu J; Xiao H; Huang Y
    Biomed Chromatogr; 2016 Oct; 30(10):1591-8. PubMed ID: 27028459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.
    Lam YW; Alfaro CL; Ereshefsky L; Miller M
    J Clin Pharmacol; 2003 Nov; 43(11):1274-82. PubMed ID: 14551182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin.
    Kerbusch T; Jansen RL; Mathôt RA; Huitema AD; Jansen M; van Rijswijk RE; Beijnen JH
    Clin Pharmacol Ther; 2001 Aug; 70(2):132-41. PubMed ID: 11503007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults.
    Townsend R; Dietz A; Hale C; Akhtar S; Kowalski D; Lademacher C; Lasseter K; Pearlman H; Rammelsberg D; Schmitt-Hoffmann A; Yamazaki T; Desai A
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):44-53. PubMed ID: 27273461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects.
    Dutreix C; Peng B; Mehring G; Hayes M; Capdeville R; Pokorny R; Seiberling M
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):290-4. PubMed ID: 15138710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic drug interactions with rifampicin.
    Venkatesan K
    Clin Pharmacokinet; 1992 Jan; 22(1):47-65. PubMed ID: 1559307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated gatifloxacin and reduced rifampicin concentrations in a single-dose interaction study amongst healthy volunteers.
    McIlleron H; Norman J; Kanyok TP; Fourie PB; Horton J; Smith PJ
    J Antimicrob Chemother; 2007 Dec; 60(6):1398-401. PubMed ID: 17951604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.